183 related articles for article (PubMed ID: 22679108)
1. GSK-3 promotes cell survival, growth, and PAX3 levels in human melanoma cells.
Kubic JD; Mascarenhas JB; Iizuka T; Wolfgeher D; Lang D
Mol Cancer Res; 2012 Aug; 10(8):1065-76. PubMed ID: 22679108
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of GSK-3beta ameliorates hepatic ischemia-reperfusion injury through GSK-3beta/beta-catenin signaling pathway in mice.
Xia YX; Lu L; Wu ZS; Pu LY; Sun BC; Wang XH
Hepatobiliary Pancreat Dis Int; 2012 Jun; 11(3):278-84. PubMed ID: 22672822
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of glycogen synthase kinase-3beta, a downstream target of the raf-1 pathway, is associated with growth suppression in medullary thyroid cancer cells.
Kunnimalaiyaan M; Vaccaro AM; Ndiaye MA; Chen H
Mol Cancer Ther; 2007 Mar; 6(3):1151-8. PubMed ID: 17363508
[TBL] [Abstract][Full Text] [Related]
4. Glycogen synthase kinase 3 regulates PAX3-FKHR-mediated cell proliferation in human alveolar rhabdomyosarcoma cells.
Zeng FY; Dong H; Cui J; Liu L; Chen T
Biochem Biophys Res Commun; 2010 Jan; 391(1):1049-55. PubMed ID: 19995556
[TBL] [Abstract][Full Text] [Related]
5. GSK-3 inhibitor inhibits cell proliferation and induces apoptosis in human osteosarcoma cells.
Nishimura H; Nakamura O; Yamagami Y; Mori M; Horie R; Fukuoka N; Yamamoto T
Oncol Rep; 2016 Apr; 35(4):2348-54. PubMed ID: 26781995
[TBL] [Abstract][Full Text] [Related]
6. Glycogen synthase kinase-3β is a crucial mediator of signal-induced RelB degradation.
Neumann M; Klar S; Wilisch-Neumann A; Hollenbach E; Kavuri S; Leverkus M; Kandolf R; Brunner-Weinzierl MC; Klingel K
Oncogene; 2011 May; 30(21):2485-92. PubMed ID: 21217772
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of glycogen synthase kinase-3beta is sufficient for airway smooth muscle hypertrophy.
Deng H; Dokshin GA; Lei J; Goldsmith AM; Bitar KN; Fingar DC; Hershenson MB; Bentley JK
J Biol Chem; 2008 Apr; 283(15):10198-207. PubMed ID: 18252708
[TBL] [Abstract][Full Text] [Related]
8. Glycogen Synthase Kinase-3 regulates multiple myeloma cell growth and bortezomib-induced cell death.
Piazza F; Manni S; Tubi LQ; Montini B; Pavan L; Colpo A; Gnoato M; Cabrelle A; Adami F; Zambello R; Trentin L; Gurrieri C; Semenzato G
BMC Cancer; 2010 Oct; 10():526. PubMed ID: 20920357
[TBL] [Abstract][Full Text] [Related]
9. GSK-3β inhibition promotes cell death, apoptosis, and in vivo tumor growth delay in neuroblastoma Neuro-2A cell line.
Dickey A; Schleicher S; Leahy K; Hu R; Hallahan D; Thotala DK
J Neurooncol; 2011 Aug; 104(1):145-53. PubMed ID: 21161565
[TBL] [Abstract][Full Text] [Related]
10. [Glycogen synthase kinase-3beta (GSK-3beta) promotes proliferation of ovarian cancer cells in vitro].
Cao Q; Feng YJ
Zhonghua Zhong Liu Za Zhi; 2006 Nov; 28(11):804-9. PubMed ID: 17415999
[TBL] [Abstract][Full Text] [Related]
11. GSK-3β inhibition attenuates LPS-induced death but aggravates radiation-induced death via down-regulation of IL-6.
Li B; Zhang C; He F; Liu W; Yang Y; Liu H; Liu X; Wang J; Zhang L; Deng B; Gao F; Cui J; Liu C; Cai J
Cell Physiol Biochem; 2013; 32(6):1720-8. PubMed ID: 24356466
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of glycogen synthase kinase-3β counteracts ligand-independent activity of the androgen receptor in castration resistant prostate cancer.
Schütz SV; Schrader AJ; Zengerling F; Genze F; Cronauer MV; Schrader M
PLoS One; 2011; 6(9):e25341. PubMed ID: 21980429
[TBL] [Abstract][Full Text] [Related]
13. Serine 9 and tyrosine 216 phosphorylation of GSK-3β differentially regulates autophagy in acquired cadmium resistance.
Park CH; Lee BH; Ahn SG; Yoon JH; Oh SH
Toxicol Sci; 2013 Oct; 135(2):380-9. PubMed ID: 23897984
[TBL] [Abstract][Full Text] [Related]
14. Glycogen synthase kinase-3 is a negative regulator of extracellular signal-regulated kinase.
Wang Q; Zhou Y; Wang X; Evers BM
Oncogene; 2006 Jan; 25(1):43-50. PubMed ID: 16278684
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of GSK-3beta decreases NF-kappaB-dependent gene expression and impairs the rat liver regeneration.
Chen H; Yang S; Yang Z; Ma L; Jiang D; Mao J; Jiao B; Cai Z
J Cell Biochem; 2007 Dec; 102(5):1281-9. PubMed ID: 17427960
[TBL] [Abstract][Full Text] [Related]
16. Differential modulatory effects of GSK-3β and HDM2 on sorafenib-induced AIF nuclear translocation (programmed necrosis) in melanoma.
Liu Q; Mier JW; Panka DJ
Mol Cancer; 2011 Sep; 10():115. PubMed ID: 21929745
[TBL] [Abstract][Full Text] [Related]
17. From a natural product lead to the identification of potent and selective benzofuran-3-yl-(indol-3-yl)maleimides as glycogen synthase kinase 3beta inhibitors that suppress proliferation and survival of pancreatic cancer cells.
Gaisina IN; Gallier F; Ougolkov AV; Kim KH; Kurome T; Guo S; Holzle D; Luchini DN; Blond SY; Billadeau DD; Kozikowski AP
J Med Chem; 2009 Apr; 52(7):1853-63. PubMed ID: 19338355
[TBL] [Abstract][Full Text] [Related]
18. GSK-3β activation mediates Nogo-66-induced inhibition of neurite outgrowth in N2a cells.
Shen JY; Yi XX; Xiong NX; Wang HJ; Duan XW; Zhao HY
Neurosci Lett; 2011 Nov; 505(2):165-70. PubMed ID: 22019984
[TBL] [Abstract][Full Text] [Related]
19. Small-molecule GSK-3 inhibitor rescued apoptosis and neurodegeneration in anesthetics-injured dorsal root ganglion neurons.
Yu T; Lin W
Biomed Pharmacother; 2016 Dec; 84():395-402. PubMed ID: 27668540
[TBL] [Abstract][Full Text] [Related]
20. Glycogen synthase kinase-3beta regulates differentiation-induced apoptosis of human neural progenitor cells.
Jaeger A; Baake J; Weiss DG; Kriehuber R
Int J Dev Neurosci; 2013 Feb; 31(1):61-8. PubMed ID: 23085082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
